Clinical Scientist, Clinical Development
Abata TherapeuticsSalary not specified
Full Time
Mid-level (3 to 4 years), Senior (5 to 8 years)
[Remote] Medical Director, Clinical Development at Amylyx Pharmaceuticals
Cambridge, Massachusetts, United States
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries
Skills
Key technologies and capabilities for this role
Questions & Answers
Common questions about this position
What is the location for this position?
The position is located in Cambridge, Massachusetts.
What is the salary range for this role?
This information is not specified in the job description.
What are the required qualifications for this role?
Candidates must have an MD, with strong preference for experience in late-stage clinical development and drug development in rare diseases, plus 4+ years of experience leading clinical programs.
What does the team structure look like for this position?
The role involves managing a small team of clinical scientists and physicians, reporting to the Senior VP of Clinical Development.
What experience makes a strong candidate for this Medical Director role?
Strong candidates will have an MD with 4+ years leading clinical development, especially in late-stage programs and rare diseases like endocrine conditions, plus expertise in endocrinology.
Amylyx Pharmaceuticals
Develops treatments for neurodegenerative diseases
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, focusing on conditions like Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (ALZ). Their main product, AMX0035, is currently undergoing clinical trials to assess its effectiveness. The CENTAUR ALS trial showed promising results for ALS patients, using a randomized, double-blind, placebo-controlled design to ensure reliable outcomes. They are also conducting the PEGASUS trial to evaluate AMX0035's safety and effectiveness in Alzheimer's patients. Unlike many competitors, Amylyx emphasizes community engagement and awareness campaigns, such as ALS Awareness Month, to educate the public and foster support for those affected by these diseases. The company's goal is to bring effective therapies to market that improve patient outcomes and enhance the quality of life for individuals suffering from neurodegenerative conditions.
Cambridge, MassachusettsHeadquarters
2013Year Founded
$166.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees
Benefits
Remote Work Options
Risks
Relyvrio's Phase III failure raises concerns about ALS treatment efficacy.
Low stock offering price suggests potential financial instability.
New CCO may disrupt commercialization strategies if not aligned with goals.
Differentiation
Amylyx focuses on neurodegenerative diseases like ALS and Alzheimer's.
AMX0035 is a promising drug for ALS and Alzheimer's treatment.
Amylyx engages in community awareness campaigns for neurodegenerative diseases.
Upsides
Positive Phase II results for AMX0035 in ALS boost its potential.
Partnership with Gubra accelerates drug development for neurodegenerative diseases.
Regulatory support for rare diseases aids Amylyx's Wolfram syndrome efforts.
Related Jobs
RemoteRemoteSenior Clinical Trial Manager / Associate Director
Abata TherapeuticsSalary not specified
- Full Time
- Mid-level (3 to 4 years), Senior (5 to 8 years)
RemoteMedical Director, Clinical Development
Abata TherapeuticsSalary not specified
- Full Time
- Senior (5 to 8 years)
RemoteMedical Director/Clinical Trial Physician - Neurology(FSP)
Thermo Fisher Scientific$200,000 - $250,000/year
- Internship
- Mid-level (3 to 4 years), Senior (5 to 8 years)
RemoteDirector / Senior Director, Clinical Development Scientist
Abata TherapeuticsSalary not specified
- Full Time
- Expert & Leadership (9+ years)
RemoteAssociate Medical Director / Medical Director, Clinical Development
TempusSalary not specified
- Full Time
- Junior (1 to 2 years)